GE HealthCare launches CardioVisio for AFib digital tool in US
Getty Images/Getty Images News
GE HealthCare (NASDAQ:GEHC) said it has launched its digital tool CardioVisio for Atrial Fibrillation, or AFib, in the US.
The medtech company said the tool is aimed at helping clinicians visualize longitudinal data relevant for disease progression from multiple data sources, such as past exams, medications and interventions. The tool also offers therapy recommendations based on up-to-date AFib guidelines.
GE HealthCare was spun out by General Electric (GE) as a separately traded company in early January. 

More on GE HealthCare Technologies

VGI Partners - GE HealthCare: Under-Appreciated Opportunity As A Newly Independent Company
GE HealthCare: Good Growth Prospects At A Reasonable Valuation
GE HealthCare Technologies: Q2 2023 Earnings Solidify Bullish Case

GE HealthCare Technologies Inc. (GEHC) Q2 2023 Earnings Call Transcript
Wells Fargo starts GE HealthCare at overweight, sees increased imaging demand
GE HealthCare gets FDA clearance for Portrait Mobile patient monitor
BofA starts GE HealthCare at neutral, sees margin upside priced in
GE HealthCare Technologies beats Q2 top and bottom line estimates; raises full-year guidance
Earnings data for GE HealthCare Technologies
Dividend scorecard for GE HealthCare Technologies